Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Neurology Drugs Market Research Reports

Titlepublishedprice

Global Migraine Drugs Market Research Report 2016

By QYResearch Group
"...... l market, with Production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - AstraZeneca - Merck KGaA - Johnson & Johnson - Pfizer - Vernalis - Almirall - Royal......"
30-Nov-2016$2900

Global Epilepsy Drugs Market Research Report 2016

By QYResearch Group
"...... l market, with Production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - Pfizer - UCB - Eisai - Roche - Shire - Sunovion Pharmaceuticals - Supernus Pharmace......"
28-Nov-2016$2900

Global Epilepsy Drugs Market Professional Survey Report 2016

By QYResearch Group
"...... , import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GlaxoSm......"
28-Nov-2016$3500

Treximet -Drug Insights, 2016

By Delve Insight
"...... ovides the Treximet sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Treximet, patents information and exclusivity data, route of synthesis, competitive ......"
01-Nov-2016$1000

Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2016

By Delve Insight
"...... ent including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundin......"
01-Nov-2016$1250

Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... eport is to understand the market and pipeline status of the drugs around the Alcohol Addiction to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveIns......"
01-Nov-2016$2000

H 3 Antagonist -Pipeline Insights, 2016

By Delve Insight
"...... , Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations de......"
01-Nov-2016$1250

Alcohol Addiction-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Relpax -Drug Insights, 2016

By Delve Insight
"...... the Relpax sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Relpax, patents information and exclusivity data, route of synthesis, competitive landscape,......"
01-Nov-2016$1000

Strattera -Drug Insights, 2016

By Delve Insight
"...... provides the Strattera sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Strattera, patents information and exclusivity data, route of synthesis, competi......"
01-Nov-2016$1000

Avail upto 50% Discount on below Publisher Reports.